Validation and Assessment of Novel Morphology-Voltage-P-wave Score for Diagnosing Left Ventricular Diastolic Dysfunction in Patients With Hypertension
For patients and families
In plain language
An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.
- What is being studied
- The protocol lists: Echocardiohraphy.
- Who it may be relevant to
- Registry conditions: Hypertension. Basic parameters: 18 years — 70 years · All.
- What needs checking
- Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
- Where it takes place
- Indonesia
- Next step
- Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Unsure about the terms? Read our patient guide →
Overview
This study aimed to assess and validate the diagnostic utility of a novel Morphology-Voltage-P-wave Score (MVP Score) in identifying left ventricular diastolic dysfunction among patients with hypertension. Researchers will collect information of patient with hypertension and underwent transthoracal echocardiography assessment. The data consist of demographic data, clinical presentation, laboratory, and echocardiography result were collected by two investigators. Then, the data was analyzed by using IBM SPSS Statistics v26.
Interventions
- Diagnostic test Echocardiohraphy
Transthoracal echocardiography for diastolic function assessment
Primary outcome measures
- Diastolic Dysfunction [Time frame: Up to 1 weeks]
Eligibility criteria
Inclusion criteria
- Essential hypertension
Exclusion criteria
- Secondary or resistant hypertension
- LVEF<55%
- Congenital heart disease
- Infiltrative cardiomyopathy
- Coronary artery disease
- Chronic kidney disease
- Valvular heart disease
- Bundle branch block
- Arrhythmia
Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.
Healthy volunteers: No
Study design
- Observational model
- Case-control
Study locations
Indonesia · 1 center
- Dr. Kariadi Central General Hospital — Semarang
Identifiers
NCT: NCT06779513 · Undip_Kardio 4